BOPA 2017 | The introduction of novel immunotherapies and the pharmacist
Novel immunotherapies have great potential to improve the survival of cancer patients; however, new treatments must be introduced in a regulated manner in order to plan for anticipated, and unanticipated, side effects. Here, Islam Elkonaissi of The Royal Marsden NHS Foundation Trust, London, UK describes the crucial role pharmacists will serve in the introduction of immunotherapies for cancer. This video was recorded at the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK.
Get great new content delivered to your inboxSign up